Clinical trials for Precursor B-cell acute lymphoblastic leukemia
8 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07441291CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCTPeking University People's Hospital
- RECRUITINGN/ANCT06689917JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ LeukemiaTongji Hospital · PI: Jia Wei, Doctor
- RECRUITINGPhase 2NCT07244406Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALLHebei Senlang Biotechnology Inc., Ltd. · PI: Xiaojun Huang
- RECRUITINGPhase 2NCT06554626Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALLFirst Affiliated Hospital of Zhejiang University
- RECRUITINGPhase 2NCT06111625Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALLSichuan University
- RECRUITINGPhase 1NCT04318678CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)St. Jude Children's Research Hospital · PI: Swati Naik, MD
- RECRUITINGPHASE1, PHASE2NCT03765177CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic MalignanciesOttawa Hospital Research Institute · PI: Natasha Kekre, MD
- ENROLLING BY INVITATIONNCT03226704Leukapheresis for CAR or Adoptive Cell Therapy ManufacturingNational Cancer Institute (NCI) · PI: Nirali N Shah, M.D.